| |
| Issue |
Title |
| |
| No 4S (2021) |
Preliminary results of retrospective analysis Atezolizumab and Bevacizumab in first-line therapy of advanced HCC |
Abstract
PDF (Rus)
|
|
I. А. Dzhanyan, М. V. Natrusova, V. V. Breder |
| |
| No 20 (2020) |
Prospects of application of inhibitors of PD-1/PD-L1 checkpoints in malignant tumors of the stomach and esophagogastric junction |
Abstract
PDF (Rus)
|
|
D. D. Sakaeva, A. A. Melnikova |
| |
| No 9 (2020) |
Immuno-related endocrinopathy in patients treated with immune checkpoint inhibitors |
Abstract
PDF (Rus)
|
|
D. I. Yudin, K. K. Laktionov, K. A. Sarantseva, O. I. Borisova, V. V. Breder, E. V. Reutova, M. F. Beloyartseva, S. Yu. Kruteleva, I. A. Dzhanyan |
| |
| No 19 (2019) |
Three-year results of application of nivolumab in patients with non-small cell lung cancer in clinical practice of the N.N. Blokhin Russian Cancer Research Center |
Abstract
PDF (Rus)
|
|
K. K. Laktionov, K. A. Sarantseva, D. I. Yudin, V. V. Breder, E. V. Reutova, K. P. Laktionov |
| |
| No 19 (2019) |
Will neo-adjuvant immunotherapy become a new paradigm in the treatment of lung cancer patients |
Abstract
PDF (Rus)
|
|
K. K. Laktionov, V. V. Breder, D. I. Yudin, K. A. Sarantseva, L. V. Laktionova, M. S. Ardzinba, E. V. Reutova, A. V. Egorova |
| |
| No 10 (2019) |
Pseudoprogression in patients on immunotherapy |
Abstract
PDF (Rus)
|
|
D. I. Yudin, K. K. Laktionov, K. A. Sarantseva, V. V. Breder, E. V. Reutova, O. I. Borisova, M. S. Ardzinba |
| |
| No 10 (2019) |
Immunotherapy for hepatocellular cancer: beginning and future perspectives |
Abstract
PDF (Rus)
|
|
M. A. Kazantseva, V. V. Breder, K. K. Laktionov |
| |
| No 10 (2019) |
Immunotherapy for small-cell lung cancer |
Abstract
PDF (Rus)
|
|
A. Ye. Kuzminov, K. K. Laktionov, A. A. Yegorova, V. V. Breder, T. D. Barbolina |
| |
| No 19 (2018) |
Future prospects for breast cancer immunotherapy |
Abstract
PDF (Rus)
|
|
V. F. Semiglazov, A. I. Tseluiko, R. V. Donskikh, P. V. Krivorotko, G. A. Dashyan, V. V. Semiglazov, A. V. Komyakhov |
| |
| No 10 (2018) |
A clinical case of 3-year highly efficient pembrolizamable therapy of metasatic lung adenocarcinoma |
Abstract
PDF (Rus)
|
|
K. K. Laktionov, D. I. Yudin, K. A. Sarantseva, K. P. Laktionov, V. V. Breder, E. V. Reutova |
| |
| No 6 (2017) |
PEMBROLIZUMAB IN THE TREATMENT OF METASTATIC MELANOMA |
Abstract
PDF (Rus)
|
|
I. V. SAMOILENKO, L. V. DEMIDOV |
| |
| 1 - 11 of 11 Items |
|
